Dave Schulte Archives - CDR – Chain Drug Review

McKesson names Tom Rodgers EVP and chief strategy and business development officer

June 9, 2020 by Chain Drug Review Brian Tyler, Dave Schulte, McKesson Corp., Tom Rodgers Business, Leading Headlines

IRVING, Texas – McKesson Corp. recently announced that Tom Rodgers has been appointed executive vice president and chief strategy and business development officer effective June 5th. In his new role, Rodgers will also become a member of the company’s executive operating team. Rodgers succeeds Bansi Nagji who stepped down from his role effective March 31,

McKesson Ventures donates $10,000 to Meals on Wheels America

June 26, 2018 by Bill Schiffner Dave Schulte, McKesson Corporation, McKesson Ventures Business, Retail News

SAN FRANCISCO – McKesson Ventures, the venture capital arm of McKesson Corporation, announced that it has donated $10,000 to Meals on Wheels America on behalf of its former portfolio company Landmark Health, a leading provider of in-home, risk-based medical care. As part of its deep commitment to supporting the growth and mission of its portfolio companies, McKesson